Suppr超能文献

外胚层发育不良蛋白 A 在眼表面稳态中的作用。

The Role of Ectodysplasin A on the Ocular Surface Homeostasis.

机构信息

Eye Institute of Xiamen University and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen 361000, China.

Fujian Provincial Key Laboratory of Corneal & Ocular Surface Diseases, Xiamen 361000, China.

出版信息

Int J Mol Sci. 2022 Dec 10;23(24):15700. doi: 10.3390/ijms232415700.

Abstract

Ectodysplasin A (EDA), a ligand of the TNF family, plays an important role in maintaining the homeostasis of the ocular surface. EDA is necessary for the development of the meibomian gland, the lacrimal gland, as well as the proliferation and barrier function of the corneal epithelium. The mutation of EDA can induce the destruction of the ocular surface resulting in keratopathy, abnormality of the meibomian gland and maturation of the lacrimal gland. Experimental animal studies showed that a prenatal ultrasound-guided intra-amniotic injection or postnatal intravenous administration of soluble recombinant EDA protein can efficiently prevent the development of ocular surface abnormalities in EDA mutant animals. Furthermore, local application of EDA could restore the damaged ocular surface to some extent. Hence, a recombinant EDA-based therapy may serve as a novel paradigm to treat ocular surface disorders, such as meibomian gland dysfunction and corneal epithelium abnormalities.

摘要

外胚层发育不良蛋白 A(EDA)是肿瘤坏死因子家族的配体,在维持眼表稳态中发挥着重要作用。EDA 对于睑板腺、泪腺的发育以及角膜上皮的增殖和屏障功能至关重要。EDA 的突变会导致眼表破坏,引发角膜病变、睑板腺异常和泪腺成熟障碍。实验动物研究表明,产前超声引导下羊膜内注射或产后静脉内给予可溶性重组 EDA 蛋白可以有效地预防 EDA 突变动物眼表异常的发生。此外,局部应用 EDA 可以在一定程度上修复受损的眼表。因此,基于 EDA 的重组治疗可能成为治疗眼表疾病(如睑板腺功能障碍和角膜上皮异常)的一种新范例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf3/9779463/82187505cdfe/ijms-23-15700-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验